Is Astellas Pharma Inc. (ALPMY) a Buy, Sell, or Hold?
OTC : ALPMY
Astellas Pharma Inc. — Competitors
$14.79 USD
$0.5 (3.5%)
- Volume
- 2.9K
- Average Volume
- 202.79K
- Market Capitalization
- $26.52B
- P/E Ratio
- 14.30
- Dividend Yield
- 3.35%
- Price Target
- Year High
- $17.35
- Year Low
- $10.03
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.47
- Current Ratio
- $1.17
ALPMY vs. The Competition
| Properties | ALPMY | BMXXY | CHJTF | GIKLY |
|---|---|---|---|---|
| Market Cap | $26.52B | $10.4B | $12.2B | $13.4B |
| Shares Outstanding | $1.79B | $1.18B | $11.41B | $2.63B |
| P/E Ratio | 14.3 | 18.54 | 21.94 | 15.19 |
| EPS | 162.37 | 0.39 | 0.33 | 0.33 |
| Day Low | 14.69 | 8.82 | 1.07 | 5.1 |
| Day High | 14.79 | 8.82 | 1.07 | 5.13 |
| Year Low | 10.03 | 7.12 | 0.94 | 5.06 |
| Year High | 17.35 | 14.62 | 1.39 | 7.49 |
| Average Price 50 | 13.469 | 8.14101 | 1.0166 | 5.2874 |
| Average Price 200 | 13.99185 | 11.36144 | 1.0604 | 5.81845 |
| Volume | 2903 | 1598 | 5000 | 1 |
| Average Volume | - | - | - | - |